Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: PLoS ONE ; Band 7 (2012), Heft 10. - S.e48042:1-e48042:6. - ISSN 1932-6203
- Event
-
Veröffentlichung
- (where)
-
Kiel
- (who)
-
Universitätsbibliothek Kiel
- (when)
-
2012
- Creator
-
Maetzler, Walter
Tian, Youyong
Baur, Stephanie Maria
Gauger, Tina
Odoj, Bartholomäus
Schmid, Benjamin
Schulte, Claudia
Deuschle, Christian
Heck, Susanna
Apel, Anja
Melms, Arthur
Gasser, Thomas
Berg, Daniela
- URN
-
urn:nbn:de:gbv:8-publ-22915
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:52 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maetzler, Walter
- Tian, Youyong
- Baur, Stephanie Maria
- Gauger, Tina
- Odoj, Bartholomäus
- Schmid, Benjamin
- Schulte, Claudia
- Deuschle, Christian
- Heck, Susanna
- Apel, Anja
- Melms, Arthur
- Gasser, Thomas
- Berg, Daniela
- Universitätsbibliothek Kiel
Time of origin
- 2012
Other Objects (12)
Biomarkers in Alzheimer's disease and lewy body disorders with dementia.
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
VGF peptides in cerebrospinal fluid of patients with dementia with lewy bodies
Dementia and geriatric cognitive disorders, [...]. Extra
Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Serum Heart-Type Fatty Acid-Binding Protein and Cerebrospinal Fluid Tau: Marker Candidates for Dementia with Lewy Bodies
The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies
Dementia-associated changes of immune cell composition within the cerebrospinal fluid
Automatic Detection of Dementia and related Affective Disorders through Processing of Speech and Language
Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables
Antibody indices of infectious pathogens from serum and cerebrospinal fluid in patients with schizophrenia spectrum disorders
Neurotoxicity and aggregation of β-synuclein and its P123H and V70M mutants associated with dementia with Lewy bodies
Biomarkers in Alzheimer's disease and lewy body disorders with dementia.
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
VGF peptides in cerebrospinal fluid of patients with dementia with lewy bodies
Dementia and geriatric cognitive disorders, [...]. Extra
Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Serum Heart-Type Fatty Acid-Binding Protein and Cerebrospinal Fluid Tau: Marker Candidates for Dementia with Lewy Bodies
The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies
Dementia-associated changes of immune cell composition within the cerebrospinal fluid
Automatic Detection of Dementia and related Affective Disorders through Processing of Speech and Language
Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables
Antibody indices of infectious pathogens from serum and cerebrospinal fluid in patients with schizophrenia spectrum disorders
Neurotoxicity and aggregation of β-synuclein and its P123H and V70M mutants associated with dementia with Lewy bodies
Biomarkers in Alzheimer's disease and lewy body disorders with dementia.
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
VGF peptides in cerebrospinal fluid of patients with dementia with lewy bodies
Dementia and geriatric cognitive disorders, [...]. Extra
Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Serum Heart-Type Fatty Acid-Binding Protein and Cerebrospinal Fluid Tau: Marker Candidates for Dementia with Lewy Bodies
The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies
Dementia-associated changes of immune cell composition within the cerebrospinal fluid
Automatic Detection of Dementia and related Affective Disorders through Processing of Speech and Language
Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables
Antibody indices of infectious pathogens from serum and cerebrospinal fluid in patients with schizophrenia spectrum disorders